Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹2,830 Cr
verified against source
Revenue YoY
3.6%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Dabur's Q4 FY25 consolidated revenue grew 3.6% in consumer currency terms to INR 12,563 crore, with PAT of INR 1,768 crore. India business declined ~3.4% due to inventory correction, high bases, and unfavorable seasons, while international business grew 19.3% in consumer currency. Gross margin contracted ~240bps in standalone due to inflation not fully passed through. Management outlined a seven-pillar strategy with McKinsey, targeting sustainable double-digit CAGR by FY28, including premiumization, portfolio rationalization (exiting tea, diapers, Vita), and M&A. Guidance for FY26 is high single-digit value growth, with sequential improvement expected. Risks include competitive intensity in beverages and oral care, and potential margin pressure from recycled plastic mandates.
Colored figures show movement against the previous available record.
Guidance to track
- Management expects full-year FY26 India business to achieve high single-digit value growth, with sequential improvement through the year.
- Dabur aims to achieve sustainable double-digit CAGR in both top line and bottom line by financial year 2028.
- Management plans to exit tea, baby diapers, and Vita (MFD) categories, which are margin-dilutive and contribute less than 1% of revenue.
Risks flagged
- Beverage segment faces heightened competition from Campa Cola and others, with management expecting only low to mid-single-digit growth in FY26.
- Inflation and inability to fully pass through price increases led to 240bps gross margin contraction. Upcoming recycled plastic regulations could further pressure margins.
- Healthcare sales remain at FY21 levels, and beverages face structural challenges. Recovery is expected to be gradual, with no quick turnaround.
Key quotes
- Our ambition is to achieve a sustainable double-digit CAGR by financial year 2028 in both top line and also bottom line.
- We shall weed and feed our portfolio, and portfolio rationalization will happen. A clear exit path for some of the categories which have been non-performers have been identified to release capital.
- We are a plastic positive company. In a sense, we are recycling more of plastic than what we are consuming ourselves.
Research modules